antimycin

Suppliers

Names

[ CAS No. ]:
11118-72-2

[ Name ]:
antimycin

Chemical & Physical Properties

[ Density]:
1.379g/cm3

[ Boiling Point ]:
409.826ºC at 760 mmHg

[ Molecular Formula ]:
C13H14O5

[ Molecular Weight ]:
250.24700

[ Flash Point ]:
156.641ºC

[ Exact Mass ]:
250.08400

[ PSA ]:
83.83000

[ LogP ]:
1.72100

[ Vapour Pressure ]:
0mmHg at 25°C

[ Index of Refraction ]:
1.596

Toxicological Information

CHEMICAL IDENTIFICATION

RTECS NUMBER :
CD0174900
CHEMICAL NAME :
Antimycin
CAS REGISTRY NUMBER :
11118-72-2
LAST UPDATED :
199710

HEALTH HAZARD DATA

ACUTE TOXICITY DATA

TYPE OF TEST :
LD50 - Lethal dose, 50 percent kill
ROUTE OF EXPOSURE :
Oral
SPECIES OBSERVED :
Rodent - rat
DOSE/DURATION :
28 mg/kg
TOXIC EFFECTS :
Details of toxic effects not reported other than lethal dose value
REFERENCE :
TAFSAI Transactions of the American Fisheries Society. (American Fisheries Soc., 5410 Grosvenor Lane, Bethesda, MD 20014) V.1- 1870- Volume(issue)/page/year: 96,320,1967
TYPE OF TEST :
LD50 - Lethal dose, 50 percent kill
ROUTE OF EXPOSURE :
Intraperitoneal
SPECIES OBSERVED :
Rodent - rat
DOSE/DURATION :
1600 ug/kg
TOXIC EFFECTS :
Details of toxic effects not reported other than lethal dose value
REFERENCE :
TAFSAI Transactions of the American Fisheries Society. (American Fisheries Soc., 5410 Grosvenor Lane, Bethesda, MD 20014) V.1- 1870- Volume(issue)/page/year: 96,320,1967
TYPE OF TEST :
LD50 - Lethal dose, 50 percent kill
ROUTE OF EXPOSURE :
Oral
SPECIES OBSERVED :
Rodent - mouse
DOSE/DURATION :
55 mg/kg
TOXIC EFFECTS :
Details of toxic effects not reported other than lethal dose value
REFERENCE :
TAFSAI Transactions of the American Fisheries Society. (American Fisheries Soc., 5410 Grosvenor Lane, Bethesda, MD 20014) V.1- 1870- Volume(issue)/page/year: 96,320,1967
TYPE OF TEST :
LD50 - Lethal dose, 50 percent kill
ROUTE OF EXPOSURE :
Intraperitoneal
SPECIES OBSERVED :
Rodent - mouse
DOSE/DURATION :
1700 ug/kg
TOXIC EFFECTS :
Details of toxic effects not reported other than lethal dose value
REFERENCE :
TAFSAI Transactions of the American Fisheries Society. (American Fisheries Soc., 5410 Grosvenor Lane, Bethesda, MD 20014) V.1- 1870- Volume(issue)/page/year: 96,320,1967
TYPE OF TEST :
LD50 - Lethal dose, 50 percent kill
ROUTE OF EXPOSURE :
Oral
SPECIES OBSERVED :
Mammal - dog
DOSE/DURATION :
>5 mg/kg
TOXIC EFFECTS :
Details of toxic effects not reported other than lethal dose value
REFERENCE :
TAFSAI Transactions of the American Fisheries Society. (American Fisheries Soc., 5410 Grosvenor Lane, Bethesda, MD 20014) V.1- 1870- Volume(issue)/page/year: 96,320,1967
TYPE OF TEST :
LD50 - Lethal dose, 50 percent kill
ROUTE OF EXPOSURE :
Oral
SPECIES OBSERVED :
Rodent - rabbit
DOSE/DURATION :
10 mg/kg
TOXIC EFFECTS :
Details of toxic effects not reported other than lethal dose value
REFERENCE :
TAFSAI Transactions of the American Fisheries Society. (American Fisheries Soc., 5410 Grosvenor Lane, Bethesda, MD 20014) V.1- 1870- Volume(issue)/page/year: 96,320,1967
TYPE OF TEST :
LD50 - Lethal dose, 50 percent kill
ROUTE OF EXPOSURE :
Oral
SPECIES OBSERVED :
Rodent - guinea pig
DOSE/DURATION :
1800 ug/kg
TOXIC EFFECTS :
Behavioral - convulsions or effect on seizure threshold Lungs, Thorax, or Respiration - dyspnea Lungs, Thorax, or Respiration - cyanosis
REFERENCE :
TAFSAI Transactions of the American Fisheries Society. (American Fisheries Soc., 5410 Grosvenor Lane, Bethesda, MD 20014) V.1- 1870- Volume(issue)/page/year: 96,320,1967
TYPE OF TEST :
LD50 - Lethal dose, 50 percent kill
ROUTE OF EXPOSURE :
Oral
SPECIES OBSERVED :
Bird - quail
DOSE/DURATION :
39 mg/kg
TOXIC EFFECTS :
Details of toxic effects not reported other than lethal dose value
REFERENCE :
TAFSAI Transactions of the American Fisheries Society. (American Fisheries Soc., 5410 Grosvenor Lane, Bethesda, MD 20014) V.1- 1870- Volume(issue)/page/year: 96,320,1967

Related Compounds

  • antimycina3
  • Antimycin A
  • antimycin A
  • Antimycin A
  • Antimycin A4
  • antimycin A3
  • tert-Butyl 4-(7-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)quinazolin-4-yl)piperazine-1-carboxylate
  • 2,4-Diphenyl-6-(2''-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-[1,1':3',1''-terphenyl]-2-yl)-1,3,5-triazine
  • Methyl 3-(2,6-dibromophenyl)-5-methylisoxazole-4-carboxylate
  • (2R,3S,4R,5R)-2-((Bis(4-methoxyphenyl)(phenyl)methoxy)methyl)-4-((tert-butyldimethylsilyl)oxy)-5-(2-isobutyramido-6-oxo-1,6-dihydro-9H-purin-9-yl)tetrahydrofuran-3-yl (2-cyanoethyl) diisopropylphosphoramidite
  • 2-Bromo-4-(tert-butyl)benzoyl chloride
  • 4-(5-(Bis(6-mercaptohexyl)amino)-5-oxo-1-(((perfluorophenoxy)carbonyl)oxy)pentyl)phenyl (3-(dimethylamino)propyl)(methyl)carbamate
  • 2-Amino-3-chloro-6-[(trimethylsilyl)ethynyl]phenol
  • Tris(tributylamine) bis(diphosphate)
  • (2S,4R)-5-([1,1'-Biphenyl]-4-yl)-4-(2,5-dioxopyrrolidin-1-yl)-2-methylpentanoic acid
  • (1R)-1-(3,4-Dihydroxyphenyl)-2-(methylamino)ethane-1-sulfonic Acid Sodium Salt
The content on this webpage is sourced from various professional data sources. If you have any questions or concerns regarding the content, please feel free to contact service1@chemsrc.com.